Clinitek Microalbumin 9 reagent strips for the early detection and monitoring of kidney disease

Anticipated publication date:

Clinitek Microalbumin 9 reagent strips for the early detection and monitoring of kidney disease
 
Status
In progress
Anticipated publication date
TBC
Notification date
January 2012

Provisional Schedule

Submission Date: TBC
Topic Selection: TBC
Draft guidance meeting TBC
Consultation opens: TBC
Consultation ends: TBC
Final guidance meeting: TBC

Project Team

Patient Involvement Lead: Laura Norburn
Analyst: TBC
Communications Lead: Tonya Gillis
Project manager:

Marlon Hope

Implementation Lead: Katie Worrall

Stakeholders

  • NICE is developing guidance on this technology. If you would like to become a registered stakeholder in the development of guidance on this technology, please complete a stakeholder registration and confidentiality form (Word), and return to us at medtech@nice.org.uk.

    Registered stakeholders will be informed of key stages in the development of guidance including when documents go out to consultation or comment.

Timeline

Key events during the development of the guidance

Date
Update
6 December 2012
The National Institute for Health and Clinical Excellence (NICE) is evaluating this technology. For further details on the process please see the Process and Methods Guides.
Get involved